You are here

EBV

No news is bad news for Atara

EP Vantage

Wed, 07/13/22 - 09:58 am

Atara Biotherapeutics

clinical trials

mRNA Epstein-Barr Virus Vaccine Candidate Launches Phase 1 Study

Precision Vaccines

Wed, 01/5/22 - 10:20 am

Moderna Therapeutics

clinical trials

ASH: With PhIII data in hand, Atara eyes a submission to treat a small but desperate group of transplant patients

Endpoints

Mon, 12/13/21 - 11:47 pm

FDA Gives OK for Viracta’s Phase Ib/II Trial of Oral Combo in Epstein-Barr Virus Tumors

BioSpace

Wed, 07/21/21 - 08:50 pm

Viracta Therapeutics

clinical trials